Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series

by Wang, Janice, Hajizadeh, Negin, Moore, Ernest E., McIntyre, Robert C., Moore, Peter K., Veress, Livia A., Yaffe, Michael B., Moore, Hunter B., Barrett, Christopher D.
Published 2020

Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis

by Choudhury, Rashikh, Barrett, Christopher D., Moore, Hunter B., Moore, Ernest E., McIntyre, Robert C., Moore, Peter K., Talmor, Daniel S., Nydam, Trevor L., Yaffe, Michael B.
Published 2020

STudy of Alteplase for Respiratory failure in SARS‐Cov2/COVID‐19: Study Design of the Phase IIa STARS Trial

by Moore, Hunter B., Barrett, Christopher D, Moore, Ernest E., Jhunjhnuwala, Rashi, McIntyre, Robert C., Moore, Peter K, Wang, Janice, Hajizadeh, Negin, Talmor, Daniel S., Sauaia, Angela, Yaffe, Michael B
Published 2020

Fibrinolytic Therapy for Refractory COVID‐19 Acute Respiratory Distress Syndrome: Scientific Rationale and Review

by Barrett, Christopher D., Moore, Hunter B., Moore, Ernest E., McIntyre, Robert C., Moore, Peter K, Burke, John, Hua, Fei, Apgar, Joshua, Talmor, Daniel S., Sauaia, Angela, Liptzin, Deborah R., Veress, Livia A., Yaffe, Michael B.
Published 2020